Personal Injury Attorneys - Manhattan, Brooklyn, Queens, Long Island and the Bronx

The U.S. Food and Drug Administration's Ophthalmic Devices Panel convened last Friday to discuss post-LASIK (laser-assisted in situ keratomileusis) quality-of-life issues. Of the 7.6 million people who have undergone the procedure in the United States since the mid-1990s, 140 have written letters of complaint to the FDA. Approximately one in four people who seeks Lasik is not a good candidate. Perhaps 1 percent or fewer, suffer serious, life-changing side effects: worse vision, severe dry eye, glare, inability to drive at night. One young man committed suicide because of severe eye pain and fuzzy vision. Some patients have had to have corneal transplants when LASIK went wrong. The FDA says it is concerned that doctors are not adequately informing patients about the potential risks. The FDA advisers recommended that the agency make clearer the warnings it already provides for would-be Lasik patients: Add photographs that illustrate what people suffering certain side